Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2021
Pluristem appoints two directors to its board
Pluristem Therapeutics announced the appointments of Prof. Varda Shalev and Doron Birger to its board of directors.
2020
Pluristem announces registered direct offering
Pluristem Therapeutics announced definitive agreements with two institutional investors for a registered direct offering of 1,587,302 common shares at $9.45 per share.
2020
EIB approves €50 million financing for Pluristem
The European Investment Bank approved €50 million in non-dilutive financing for Pluristem, with the financing subject to specified milestones and intended to support research and development, including clinical development of PLX cells for COVID-19 complications.